Abstract
Influenza A virus contains a negative-sense, single-stranded RNA genome which consists of 8 segments that code for 7 structural and 3 non-structural proteins (Murphy et al. 1985). In nature, the virus undergoes antigenic changes, referred to as antigenic drift and shift, that permit it to escape from immunity induced by prior infection with related influenza A viruses (Murphy et al. 1985). Common to both types of antigenic change are alterations in the surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA) (Murphy et al. 1985). Antibodies to the HA glycoprotein neutralize the infectivity of the virus, and antibodies to the NA prevent efficient release of virus from infected cells (Askonas et al. 1982; Becht et al. 1971). Passive transfer of monoclonal antibodies to the HA or NA glycoprotein protects mice from experimental challenge with wild type influenza virus whereas those to the membrane (M) protein or nucleoprotein (NP) fail to protect (Askonas et al. 1982). Clearly, the surface glycoproteins constitute the major protective antigens against which an immune response is directed. Immunization of animals with purified NP or with NP expressed by a vaccinia virus induces partial resistance to lethal wild type virus challenge, but the level of resistance is considerably less than that induced by immunization with HA (Andrew et al. 1986; Wraith et al. 1986). It is thought that the resistance induced by immunization with NP is mediated primarily by histocompatibility class I restricted cytotoxic T-cells, but is not limited to this T-cell subset (McDermott et al. 1987; Taylor et al. 1986).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andrew ME, Coupar BEH, Ada GL, Boyle DB (1986) Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants. Microb Pathogen 1:443–452
Askonas BA, McMichael AJ, Webster RG (1982) The immune response to influenza viruses and the problem of protection against infection. In: Basic and Applied Influenza Research. AS Beare (ed), Boca Raton, Florida, CRC Press p. 159
Becht H, Hammerling U, Rott R (1971) Undisturbed release of influenza virus in the presence of univalent anti-neuraminidase antibodies. Virology 46:337–343
Brandtzaeg P (1981) Transport models for secretory IgA and secretory IgM. Clin Exp Immunol 44:221–232
Brown TA, Clements ML, Murphy BR, Radl J, Haaijman JJ, Mestecky J (1987) Molecular form and subclass distribution of IgA antibodies after immunization with live and inactivated influenza A vaccines. Adv Exp Med Biol 216B:1691–1700
Brown TA, Murphy BR, Radl J, Haaijman JJ/ Mestecky J (1985) Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans. J Clin Microbiol 22:259–264
Burlington DB, Clements ML, Meiklejohn G, Phelan M, Murphy BR (1983) Hemagglutinin-specific antibody responses in immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans. J Clin Microbiol 41:540–545
Chen KS, Burlington DB, Quinnan Jr GV (1987) Active synthesis of hemmagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccine. J Virol 61:2150–2154
Clements ML, Betts RF, Murphy BR (1984) Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A /Washington/ 80 (H3N2) wild-type virus infection. Lancet i:705–708
Clements ML, Murphy BR (1986a) Development and persistance of local and systemic antibody responses in adults given live attenuated or inactivated influenza A vaccine. J Clin Microbiol 23:66–72
Clements ML, Betts RF, Tierney EL, Murphy BR (1986b) Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J Clin Microbiol 24:157–160
Clements ML, O’Donnell S, Levine MM, Chanock RM, Murphy BR (1983) Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: Role of local antibody in resistance to infection with vaccine virus. Infect Immun 40:1044–1051
Clements ML, Betts RF, Tierney EL, Murphy BR (1986c) Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine. J Clin Microbiol 23:73–76
Couch RB, Kasel JA, Gerin JL, Schulman JL, Kilbourne ED (1974) Induction of partial immunity to influenza by a neuraminidase-specific vaccine. J Infect Dis 129:411–420
Ennis FA, Hua QY, Schild GC, Pratt R, Potter CW (1981) HLA-restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines. Lancet ii:887–891
Ennis FA, Hua QY, Schild GC (1982) Antibody and cytotoxic T lymphocyte responses of humans to live and inactivated influenza vaccines. J Gen Virol 58:273–281
Glezen WP (1980) Consideration of the risk of influenza in children and indications for prophylaxis. Rev Infect Dis 2:408–420
Johnson PR, Feldman S, Thompson JM, Mahoney JD, Wright PF (1986) Immunity to influenza A virus infection in young children: A Comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J Infect Dis 154:121–127
Leung KN, Ada GL (1980) Cells mediating delayed-type hypersensitivity in the lungs of mice infected with an influenza A virus. Scand J Immunol 12:393–400
McMichael AJ, Gotch FM, Noble GR, Beare PAS (1983) Cytotoxic T-cell immunity to influenza. N Engl J Med 309:13–17
McDermott MR, Lukacher AE, Braciale VL, Braciale TJ, Bienenstock J (1987) Characterization and in vivo distribution of influenza-virus-specific T-lymphocytes in the murine respiratory tract. Am Rev Resp Dis 135:245–249
Mills J, Van Kirk JE, Wright PF, Chanock RM (1971) Experimental respiratory syncytial virus infection of adults. J Immunol 107:123–130
Murphy BR, Chalhub EG, Nusinoff SR, Kase J, Chanock RM (1973) Temperature-sensitive mutants of influenza virus III. Further characterization of the ts-l[E] influenza A recombinant. J Infect Dis 128:479–487
Murphy BR, Clements ML, Johnson, PR, Wright PF (In Press) The mucosal and systemic immune responses of children and adults to live and inactivated influenza A virus vaccine. In: Strober W, Lamm M, McGhee J (eds) Mucosal Immunity and Infection at Mucosal Surfaces. Oxford University Press
Murphy BR, Kasel JA, Chanock RM (1972) Association of serum anti-neuraminidase antibody with resistance to influenza in man. N Engl J Med 286:1329–1332
Murphy BR, Nelson DL, Wright PF, Tierney EL, Phelan MA, Chanock RM (1982) Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines. Infect Immun 36:1102–1108
Murphy BR, Rennels MB, Douglas Jr RG, Betts RF, Couch RB, Cate Jr TR, Chanock RM, Kendal AP, Maassab HF, Suwanagool S, Sotman SB, Cisneros LA, Anthony WC, Nalin DR, Levine MM (1980) Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers. Infect Immun 29:348–355
Murphy BR, Webster RG (1985) Influenza Viruses. In: Fields B, Knipe DM, Melnick JL, Chanock RM, Roizman B, Shope RE (eds) Virolgy. Raven Press, New York p11
Noble GR (1982) Epidemiological and clinical aspects of influenza. In: Beare AS (ed) Basic and Applied Influenza Research. Boca Raton, Florida, CRC Press, p 1179
Perkins JC, Tucker DN, Knopf HLS, Wenzael RP, Kapikian AZ, Chanock RM (1969) Comparison of protective effect of neutralizing antibody in serum and nasal secretions in experimental rhinovirus type 13 illness. Am J Epidemiol 90:519–526
Prince GA, Horswood RL, Chanock RM (1985) Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats. J Virol 55:517–520
Puck JM, Glezen WP, Frank AL, Six HR (1980) Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis 142:844–849
Reuman PD, Paganini CMA, Ayoub EM, Small Jr PA (1983) Maternal-infant transfer of influenza-specific immunity in the mouse. J Immunol 130:932–936
Small Jr PA, Ramphal R, Reuman P, Kris R (1981) Host defense against influenza virus. In: Nayak DP (ed) ICN-UCLA Symposia on Molecular and Cellular Biology. Academic Press, New York, p 441
Smith CB, Purcell RH, Bellanti JA, Chanock RM (1966) Protective effect of antibody to parainfluenza type 1 virus. N Engl J Med 21:1145–1152
Taylor PM, Askonas BA (1986) Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo. Immunology 58:417–420
Wagner DK, Clements ML, Reimer CB, Snyder M, Nelson DL, Murphy BR (1987) Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum. J Clin Microbiol 25:559–562
Waldman RH, Stone J, Bergmann CH, Khakoo R, Lazzell V, Jacknowitz A, Waldman ER, Howard S (1986) Secretory antibody following oral influenza immunization. Am J Med Sci 292:367–371
Wang ML, Skehel JJ, Wiley DC (1986) Comparative analyses of the specificities of anti-influenza hemagglutinin antibodies in human sera. J Virol 57:124–128
Wraith DC, Vessey AE, Askonas BA (1987) Purified influenza virus nucleoprotein protects mice from lethal infection. J Gen Virol 68:433–440
Wright PF, Murphy BR, Kervina M, Lawrence EM, Phelan MA, Karzon DT (1983) Secretory immunological response after intranasal inactivated influenza A virus vaccinations: Evidence for immunoglobulin A memory. Infect Immun 40:1092–1095
Wright PF, Okabe N, McKee Jr KT, Maassab HF, Karzon DT (1982) Cold-adapted recombinant influenza A virus vaccines in seronegative young children. J Infect Dis 146:71–79
Wright PF, Thompson J, Vaughn WK, Folland DS, Sell SHW, Karzon DT (1977) Trials of influenza A/New Jersey/76 virus vaccine in normal children: An overview of age-related antigenicity and reactogenicity. J Infect Dis 136:731–741
Wiley DC, Skehel JJ (1987) The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Ann Rev Biochem 56:365–394
Yarchoan R, Murphy BR, Strober W, Clements ML, Nelson DL (1981) In vitro production of anti-influenza virus antibody after intranasal inoculation with cold-adapted influenza virus. J Immunol 127:1958–1963
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Murphy, B.R., Clements, M.L. (1989). The Systemic and Mucosal Immune Response of Humans to Influenza A Virus. In: Mestecky, J., McGhee, J.R. (eds) New Strategies for Oral Immunization. Current Topics in Microbiology and Immunology, vol 146. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74529-4_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-74529-4_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74531-7
Online ISBN: 978-3-642-74529-4
eBook Packages: Springer Book Archive